There is no general consensus on the investigation and subsequent management of patients presenting with acute chest pain and elevated cardiac troponin levels, but with non-obstructive coronary arteries on angiography. This article reviews the evidence supporting the usefulness of cardiac magnetic resonance imaging in patients with acute chest pain and elevated cardiac troponin levels, but with non-obstructive coronary arteries, and offers insights into the role and future Utility of cardiac magnetic resonance imaging in troponin-positive chest pain with non-obstructive coronary arteries: literature review.
This document is a review article discussing the investigation and management of patients presenting with acute chest pain and elevated cardiac troponin levels, but with non-obstructive coronary arteries on angiography. It highlights the clinical challenges associated with this condition, known as myocardial infarction with non-obstructive coronary arteries (MINOCA) or troponin-positive chest pain with non-obstructive coronary arteries (TpNOCA).
The article focuses on the role of cardiac magnetic resonance (CMR) imaging as a first-line modality to detect the underlying aetiology in these patients. It reviews current evidence regarding the optimal timing for CMR imaging, its ability to distinguish between ischaemic and non-ischaemic causes, and its impact on prognostic information and management strategies.
Ideally, the imaging should be performed as soon as possible, though it is typically done after 1 to 4 weeks.
Performing the scan within 2 weeks allows an underlying cause to be identified in a higher percentage of patients compared to performing it after 2 weeks.
The prevalence of this condition is 6%, with a 95% confidence interval ranging from 5% to 7%.